UK-linked Heights has launched an MRI study to position its menopause range around brain health, shifting the pitch from hot flushes and night sweats to brain fog, memory lapses and reduced concentration. The brand is trying to put a scan behind a symptom that is usually reported subjectively, which makes the claim look more scientific without yet proving that a supplement changes how women feel or function.
That distinction matters because brain fog is commercially attractive and clinically awkward. It affects work, confidence and daily life, but there is no simple test that turns a bad memory day into a clean biomarker. An MRI can show structure or activation, but by itself it does not show whether a product improves concentration, recall or performance in real life.
The wider research landscape helps explain why this message lands. A 2020 review in Frontiers in Neurology, Menopause and Brain Health: Hormonal Changes Are Only Part of the Story, argued that menopause-related brain changes are shaped by more than hormone levels alone. In 2022, Climacteric published Brain fog in menopause: a health-care professional’s guide for decision-making and counseling on cognition, a sign that clinicians are actively trying to navigate these complaints rather than dismiss them. The Menopause Society says memory and other cognitive abilities change throughout life and decline with age, which is a reminder that midlife symptoms need context, not marketing spin.
Structural brain research has also pushed the subject into the mainstream. In February, ScienceDaily highlighted University of Cambridge findings linking menopause with reduced grey matter volume in several important brain regions, alongside higher levels of anxiety, depression and sleep difficulties. The Cambridge research news page made the same point in plainer language, tying menopause to loss of grey matter, poorer mental health and sleep disturbance. That is the sort of imaging result a supplement brand can point to, but it is still a far cry from proof that a tablet can fix cognitive symptoms.
NutraIngredients also covered an fMRI study in April that explored choline’s impact on the post-menopausal brain, another sign that supplement companies are using neuroimaging to dress up brain-health claims. For readers and buyers, the standard should be higher than a scan and a story: look for a clear study design, a meaningful number of participants, objective cognitive testing, and evidence that any change lasts beyond a lab session. If brain fog is new, worsening or affecting work, driving or daily life, see your GP.
